Thursday, October 3, 2019

Journals on Medical Informatics - BJSTR Journal

Abstract

To prevent earlier AD, the olfactory test could be used as a non-invasive and non-expensive tool. To do so we propose to bring together professional of the recommendations and use them to create a specific tool. The aging of the population is associated with an increase in people with #Alzheimer's disease (AD) which causes the cost of care in this population to be more expensive. To rise the opportunity to prevent or delay the AD, markers of early detection are essential. All studies are unanimous and validate the identification of odors as a #biomarker of the #preclinic stage in AD [1-2]. #Olfactive disease is a precursor to the transformation of mild cognitive impairment to AD [3] and is as sensitive as other biological biomarkers [4]. In practice there are still very few practitioners who use olfactory test on early stage. In clinical research the literature reviews point to a high variability in the tools used: either by their connotation too culturally marked, or because the choice of odors can de discuss, or the specificity of the tool is too low [5]. There is a real lack of consensus that is detrimental to the common use. To improved public health and reduce the overall cost of this disease and allow early detection, it is necessary to act as soon as possible to react before

For more articles on BJSTR Journal please click on https://biomedres.us/




follow on Tumblr : https://biomedres.tumblr.com/

follow on Pinetrest : https://www.pinterest.com/biomedres/

follow on Twitter : https://twitter.com/Biomedres01

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Gentamicin Wet Compress and Hormone Therapy for Superficial Second-Degree Burns Complicated with Atopic Dermatitis

  Gentamicin Wet Compress and Hormone Therapy for Superficial Second-Degree Burns Complicated with Atopic Dermatitis Background One of the c...